Abbott Laboratories competitors and alternatives include Stryker Corporation, Boston Scientific Corporation, etc.…
Income Statement
Assets & Liabilities | Cash Flow
Profitability
Ratios
Valuation
| 2022 | 11888000000.00 |
|---|---|
| 2023 | 10605000000.00 |
| 2024 | 10834000000.00 |
| 2025 | 11332000000.00 |
| 2022 | 4018000000.00 |
|---|---|
| 2023 | 5057000000.00 |
| 2024 | 4938000000.00 |
| 2025 | 5692000000.00 |
| 2022 | 2741000000.00 |
|---|---|
| 2023 | 3453000000.00 |
| 2024 | 3938000000.00 |
| 2025 | 3733000000.00 |
| 2022 | 565300000.00 |
|---|---|
| 2023 | 916700000.00 |
| 2024 | 945700000.00 |
| 2025 | 1163600000.00 |
| 2022 | 7804000000.00 |
|---|---|
| 2023 | 5059000000.00 |
| 2024 | 6351000000.00 |
| 2025 | 9566000000.00 |
| 2022 | 2036000000.00 |
|---|---|
| 2023 | 3136000000.00 |
| 2024 | 3487000000.00 |
| 2025 | 4283000000.00 |
| 2022 | 914000000.00 |
|---|---|
| 2023 | 1703000000.00 |
| 2024 | 2645000000.00 |
| 2025 | 3658000000.00 |
| 2022 | 304700000.00 |
|---|---|
| 2023 | 511900000.00 |
| 2024 | 630700000.00 |
| 2025 | 1077200000.00 |